Literature DB >> 10832609

Role of supraspinal tachykinins for micturition in conscious rats with and without bladder outlet obstruction.

B J Gu1, O Ishizuka, Y Igawa, O Nishizawa, K E Andersson.   

Abstract

In order to clarify the role of supraspinal tachykinins in volume-induced micturition and in bladder hyperactivity secondary to bladder outlet obstruction, conscious, normal, female Sprague-Dawley rats were investigated cystometrically before and after intracerebroventricular administration of RP 67,580, a selective antagonist of neurokinin (NK)-1 receptors and/or SR 48,968, a selective antagonist of NK-2 receptors. In normal rats, RP 67,580 or SR 48,968, at a dose of 2 nmol, caused no marked changes in cystometric parameters. Higher doses (up to 20 nmol) caused dose-dependent decreases in micturition pressure and increased bladder capacity, micturition volume and residual urine. A combination of the two drugs, each at a dose of 2 nmol, significantly decreased micturition pressure and increased bladder capacity. In rats with bladder outlet obstruction, the antagonists suppressed micturition dose-dependently, producing urinary retention in two out of eight rats already at a dose of 2 nmol. At a dose of 20 nmol, dribbling incontinence, due to urinary retention, was seen in five out of ten rats. A combination of the two drugs (2 nmol of each drug) caused urinary retention in three out of nine animals and significantly increased bladder capacity, micturition volume and residual volume. The results suggest that outflow obstruction in rats increases the effects of tachykinins in supraspinal structures involved in micturition, and that antagonism of supraspinal NK-receptors may depress the micturition reflex. Whether or not this implies that supraspinal NK-receptors can be targets for drugs aimed for inhibiting bladder hyperactivity in humans should be explored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832609     DOI: 10.1007/s002100000228

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  5 in total

1.  [New pharmacological treatment concepts for overactive bladder].

Authors:  M C Michel
Journal:  Urologe A       Date:  2003-04-25       Impact factor: 0.639

Review 2.  Neuropeptides in lower urinary tract function.

Authors:  Lauren Arms; Margaret A Vizzard
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Prospective pharmacologic therapies for the overactive bladder.

Authors:  Karl-Erik Andersson
Journal:  Ther Adv Urol       Date:  2009-06

Review 4.  Animal models in urological disease and sexual dysfunction.

Authors:  Gordon McMurray; James H Casey; Alasdair M Naylor
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 5.  Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review.

Authors:  Emilio Sacco; Riccardo Bientinesi; Pierfrancesco Bassi; Diego Currò
Journal:  Int Urogynecol J       Date:  2016-02-17       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.